Live feed07:45:19·9mSECFilingvia QuantisnowKaryopharm Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity SecuritiesByQuantisnow·Wall Street's wire, on your screen.KPTI· Karyopharm Therapeutics Inc.Health CareOriginal source